{"public_id":"cl_74bd5aa6bac5bab3ec4f2ecb06e4ce0a","status":"active","superseded_by_public_id":null,"corpus_id":221362281,"text":"Restoration of FGF21 alleviates high NAFLD activity score and attenuates TLR4-triggered hepatocyte-IL-17A expression.","confidence":0.85,"paper":{"corpus_id":221362281,"title":"Lack of FGF21 promotes NASH-HCC transition via hepatocyte-TLR4-IL-17A signaling","url":"https://sah.borca.ai/papers/221362281"},"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.85,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":2},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_158774494a378848683768ac0959081f","name":"FGF21","description":"Fibroblast growth factor 21, a protein reported to prevent NASH and delay HCC development, studied here for its effects on NASH progression and NASH-HCC transition.","types":["protein","therapeutic target"],"url":"https://sah.borca.ai/concepts/co_158774494a378848683768ac0959081f"},{"public_id":"co_4011f0ded58398df3edcf46cb09d93ee","name":"TLR4-triggered hepatocyte-IL-17A expression","description":"Expression of IL-17A in hepatocytes that is induced by TLR4 signaling and attenuated by FGF21 restoration.","types":["biological process"],"url":"https://sah.borca.ai/concepts/co_4011f0ded58398df3edcf46cb09d93ee"},{"public_id":"co_776202b79ac454ba41f26a43b7b9b62c","name":"NAFLD activity score","description":"A histological scoring system for nonalcoholic fatty liver disease activity, elevated in FGF21-deficient mice and alleviated by FGF21 restoration.","types":["measurement"],"url":"https://sah.borca.ai/concepts/co_776202b79ac454ba41f26a43b7b9b62c"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_74bd5aa6bac5bab3ec4f2ecb06e4ce0a"}